化膿性汗腺炎市場規模、佔有率、成長分析（按皮膚狀況、治療方法、臨床分期、給藥途徑、最終用戶、分銷管道和地區）—產業預測，2025 年至 2032 年

2023 年全球化化膿性汗腺炎市場規模價值 11.4 億美元，預計將從 2024 年的 12 億美元成長到 2032 年的 17.5 億美元，預測期內（2025-2032 年）的複合年成長率為 5.1%。

由於發病率上升、診斷技術的增強以及治療方法的改進，全球化化膿性汗腺炎(HSP) 市場正在經歷強勁成長。患者和醫療保健提供者意識的不斷提高也促進了市場發展。大量的研發投入推動了針對發炎管理的生技藥品和藥物輸送系統的發展，製藥公司則專注於單株抗體和免疫抑制劑的臨床試驗。孤兒藥資格認定等支持性法律規範正在刺激創新。此外，新興市場醫療基礎設施的進步和皮膚病學服務可近性的改善也推動了成長。長效注射劑和皮下藥物、先進的診斷工具和微創手術等創新正在提高治療效果並改善患者預後。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與約束

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 技術分析
• 案例研究
• 顧客購買行為分析

化膿性汗腺炎市場規模（依皮膚狀況及複合年成長率）(2025-2032)

• 市場概覽
• 粉刺
• 毛囊炎
• 深層痤瘡，如囊腫和黑頭
• 沸騰

化膿性汗腺炎市場規模（依治療方法分類）及複合年成長率（2025-2032）

• 市場概覽
• 藥品
• 外科手術
• 動態療法
• 雷射治療
• 其他

化膿性汗腺炎市場規模（依臨床分期及複合年成長率）（2025-2032）

• 市場概覽
• 哈雷第一階段
• 哈雷2級
• 哈雷3級

化膿性汗腺炎市場規模（依給藥途徑和複合年成長率） (2025-2032)

• 市場概覽
• 口服
• 腸外
• 其他

化膿性汗腺炎市場規模（依最終用戶和複合年成長率）（2025-2032 年）

• 市場概覽
• 醫院
• 專科診所
• 居家護理
• 其他

化膿性汗腺炎市場規模（依通路分類）及複合年成長率（2025-2032）

• 市場概覽
• 醫院藥房
• 零售藥局
• 網路藥局
• 其他

化膿性汗腺炎市場規模及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 按部門分類的公司佔有率分析
  • 收益同比對比（2022-2024 年）

主要企業簡介

• GlaxoSmithKline（UK）
• Dr. Reddy's Laboratories（India）
• Glenmark（India）
• Boehringer Ingelheim（Germany）
• Pfizer（USA）
• Novartis AG（Switzerland）
• Teva Pharmaceutical（Israel）
• Aurobindo Pharma（India）

結論和建議

Global Hidradenitis Suppurativa Market size was valued at USD 1.14 Billion in 2023 poised to grow to from USD 1.2 Billion in 2024 to USD 1.75 Billion by 2032, growing at a CAGR of 5.1% in the forecast period (2025-2032).

The global market for hidradenitis suppurativa is witnessing robust growth, fueled by rising incidence of the condition, enhanced diagnostics, and improved treatment modalities. Increased awareness among patients and healthcare providers is also contributing to market momentum. Significant investment in research and development has led to advancements in biologics and drug delivery systems targeting inflammation management, with pharmaceutical companies focusing on clinical trials for monoclonal antibodies and immunosuppressants. Supportive regulatory frameworks, including orphan drug designations, are fostering innovation. Furthermore, advancements in healthcare infrastructure in emerging markets and increased access to dermatology services are propelling growth. Technological innovations, such as long-acting and subcutaneous injectables, along with sophisticated diagnostic tools and minimally invasive procedures, are enhancing treatment effectiveness and supporting better patient outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Hidradenitis Suppurativa market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Hidradenitis Suppurativa Market Segments Analysis

Global Hidradenitis Suppurativa Market is segmented by Skin Condition, Treatment, Clinical Stage, Route of Administration, End-Users, Distribution Channel and region. Based on Skin Condition, the market is segmented into Pimples, Folliculitis, Deep acne Like Cyst and Blackheads and Boils. Based on Treatment, the market is segmented into Medication, Surgery, Photodynamic Therapy, Laser Treatment and Others. Based on Clinical Stage, the market is segmented into Hurley Stage 1, Hurley Stage 2 and Hurley Stage 3. Based on Route of Administration, the market is segmented into Oral, Parenteral and Others. Based on End-Users, the market is segmented into Hospitals, Specialty Clinics, Homecare and Others. Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Hidradenitis Suppurativa Market

The global market for hidradenitis suppurativa is being significantly driven by the increasing prevalence of skin diseases, which has led to a heightened demand for effective treatment options. As awareness of chronic skin conditions grows and diagnosis rates rise, there is an urgent need for innovative therapies. This has prompted pharmaceutical companies to invest heavily in research and development, resulting in the expansion of new treatment alternatives. The continuous focus on innovation is enhancing the landscape of hidradenitis suppurativa therapies, making effective management more accessible to those affected by this challenging condition.

Restraints in the Global Hidradenitis Suppurativa Market

The global market for hidradenitis suppurativa faces significant challenges due to the widespread underdiagnosis of the condition by both patients and primary care providers. Often mismanaged as a benign skin infection, hidradenitis suppurativa typically receives inadequate or delayed treatment. This lack of timely diagnosis not only exacerbates the disease progression but also hampers effective management strategies. Consequently, patients are often deprived of access to targeted therapies that could significantly improve their quality of life. This limitation ultimately hinders the overall growth and development of the hidradenitis suppurativa market, creating a pressing need for awareness and education among both healthcare professionals and patients.

Market Trends of the Global Hidradenitis Suppurativa Market

The global hidradenitis suppurativa market is witnessing significant growth driven by advancements in biologic therapies, which offer enhanced efficacy for patients suffering from moderate to severe forms of the disease. Biologics, with their targeted mechanisms of action, are outpacing traditional treatment options and have become key in improving patient outcomes. The landscape is further energized by the continuous initiation of clinical trials and the recent approvals of innovative biologic agents, fostering a dynamic environment for market expansion. This trend signifies a shift towards personalized medicine, dramatically transforming the treatment paradigm for hidradenitis suppurativa and enhancing overall patient care.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Analysis
• Case Studies
• Customer Buying Behavior Analysis

Global Hidradenitis Suppurativa Market Size by Skin Condition & CAGR (2025-2032)

• Market Overview
• Pimples
• Folliculitis
• Deep acne Like Cyst and Blackheads
• Boils

Global Hidradenitis Suppurativa Market Size by Treatment & CAGR (2025-2032)

• Market Overview
• Medication
• Surgery
• Photodynamic Therapy
• Laser Treatment
• Others

Global Hidradenitis Suppurativa Market Size by Clinical Stage & CAGR (2025-2032)

• Market Overview
• Hurley Stage 1
• Hurley Stage 2
• Hurley Stage 3

Global Hidradenitis Suppurativa Market Size by Route of Administration & CAGR (2025-2032)

• Market Overview
• Oral
• Parenteral
• Others

Global Hidradenitis Suppurativa Market Size by End-Users & CAGR (2025-2032)

• Market Overview
• Hospitals
• Specialty Clinics
• Homecare
• Others

Global Hidradenitis Suppurativa Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Others

Global Hidradenitis Suppurativa Market Size & CAGR (2025-2032)

• North America (Skin Condition, Treatment, Clinical Stage, Route of Administration, End-Users, Distribution Channel)
  • US
  • Canada
• Europe (Skin Condition, Treatment, Clinical Stage, Route of Administration, End-Users, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Skin Condition, Treatment, Clinical Stage, Route of Administration, End-Users, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Skin Condition, Treatment, Clinical Stage, Route of Administration, End-Users, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Skin Condition, Treatment, Clinical Stage, Route of Administration, End-Users, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• GlaxoSmithKline (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dr. Reddy's Laboratories (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Glenmark (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aurobindo Pharma (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations